Literature DB >> 29790454

XPO5 genetic polymorphisms in cancer risk and prognosis.

Ana Sofia Patrão1, Francisca Dias2,3, Ana Luísa Teixeira2, Joaquina Maurício1, Rui Medeiros2,4,5,6.   

Abstract

miRNAs are small noncoding RNA molecules that have a very important role in gene expression regulation and, therefore, in cell homeostasis. SNPs in certain miRNA-related genes have been shown to influence cancer risk and prognosis. miRNA cellular processing is complex and involves multiple proteins. XPO5 is a key factor in this process as it is responsible for the nuclear export of the precursor pre-miRNA to the cytoplasm, where it will be further processed to its final miRNA conformation in order to be loaded to RNA inducing silencing complex to exert its regulatory effect. SNPs in miRNA machinery related genes have previously been shown to influence carcinogenesis, but the role of XPO5 SNPs in its expression and function is not yet fully understood. In our review, we elaborate comprehensively on the role of XPO5 and how polymorphisms have been shown to influence cancer risk and prognosis to date.

Entities:  

Keywords:  SNPs; XPO5; biomarkers; cancer; miRNAs; polymorphisms

Mesh:

Substances:

Year:  2018        PMID: 29790454     DOI: 10.2217/pgs-2018-0018

Source DB:  PubMed          Journal:  Pharmacogenomics        ISSN: 1462-2416            Impact factor:   2.533


  3 in total

1.  Identification of Potential Antigens for Developing mRNA Vaccine for Immunologically Cold Mesothelioma.

Authors:  Shichao Zhang; Shuqin Li; Ya Wei; Yu Xiong; Qin Liu; Zuquan Hu; Zhu Zeng; Fuzhou Tang; Yan Ouyang
Journal:  Front Cell Dev Biol       Date:  2022-07-01

Review 2.  Involving the microRNA Targetome in Esophageal-Cancer Development and Behavior.

Authors:  Francisca Dias; Mariana Morais; Ana Luísa Teixeira; Rui Medeiros
Journal:  Cancers (Basel)       Date:  2018-10-12       Impact factor: 6.639

3.  Association between microRNA machinery gene polymorphisms and recurrent implantation failure.

Authors:  Yubin Lee; Eun Hee Ahn; Chang Soo Ryu; Jung Oh Kim; Hui Jeong An; Sung Hwan Cho; Ji Hyang Kim; Young Ran Kim; Woo Sik Lee; Nam Keun Kim
Journal:  Exp Ther Med       Date:  2020-02-26       Impact factor: 2.447

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.